Oppenheimer Asset Management Inc. Makes New $751,000 Investment in Astera Labs, Inc. (NASDAQ:ALAB)

Oppenheimer Asset Management Inc. acquired a new stake in shares of Astera Labs, Inc. (NASDAQ:ALABFree Report) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 14,337 shares of the company’s stock, valued at approximately $751,000.

Several other large investors have also recently modified their holdings of the stock. Sei Investments Co. bought a new position in Astera Labs during the 1st quarter worth approximately $952,000. Vanguard Group Inc. bought a new position in shares of Astera Labs in the first quarter worth approximately $127,268,000. Rakuten Securities Inc. purchased a new position in shares of Astera Labs in the third quarter worth $291,000. Price T Rowe Associates Inc. MD bought a new stake in Astera Labs during the 1st quarter valued at $44,514,000. Finally, Lisanti Capital Growth LLC boosted its position in Astera Labs by 99.2% during the 3rd quarter. Lisanti Capital Growth LLC now owns 59,990 shares of the company’s stock valued at $3,143,000 after buying an additional 29,875 shares during the period.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on ALAB shares. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Astera Labs from $60.00 to $100.00 and gave the company a “buy” rating in a research report on Tuesday, November 5th. Morgan Stanley upped their price objective on shares of Astera Labs from $74.00 to $94.00 and gave the stock an “overweight” rating in a report on Tuesday, November 5th. Needham & Company LLC reaffirmed a “buy” rating and set a $65.00 target price on shares of Astera Labs in a research note on Wednesday, October 9th. Stifel Nicolaus boosted their price target on Astera Labs from $80.00 to $100.00 and gave the stock a “buy” rating in a research report on Tuesday, November 5th. Finally, Craig Hallum raised their price objective on Astera Labs from $75.00 to $105.00 and gave the company a “buy” rating in a research report on Tuesday, November 5th. Twelve analysts have rated the stock with a buy rating, According to MarketBeat, the company currently has a consensus rating of “Buy” and an average price target of $94.67.

Read Our Latest Stock Report on Astera Labs

Insider Transactions at Astera Labs

In other Astera Labs news, Director Jack R. Lazar sold 3,000 shares of Astera Labs stock in a transaction that occurred on Wednesday, October 9th. The shares were sold at an average price of $61.69, for a total value of $185,070.00. Following the completion of the sale, the director now owns 137,000 shares of the company’s stock, valued at approximately $8,451,530. The trade was a 2.14 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Sanjay Gajendra sold 740,000 shares of the business’s stock in a transaction on Thursday, November 7th. The shares were sold at an average price of $96.59, for a total transaction of $71,476,600.00. Following the sale, the insider now owns 775,000 shares of the company’s stock, valued at approximately $74,857,250. This represents a 48.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 1,408,458 shares of company stock worth $113,124,841 over the last three months.

Astera Labs Trading Up 4.5 %

Shares of ALAB opened at $90.38 on Tuesday. The business’s fifty day simple moving average is $64.93 and its two-hundred day simple moving average is $59.10. Astera Labs, Inc. has a 12 month low of $36.22 and a 12 month high of $100.09.

Astera Labs (NASDAQ:ALABGet Free Report) last released its quarterly earnings data on Monday, November 4th. The company reported $0.23 EPS for the quarter, beating the consensus estimate of $0.17 by $0.06. Astera Labs had a negative return on equity of 15.57% and a negative net margin of 30.69%. The company had revenue of $113.10 million for the quarter, compared to analysts’ expectations of $97.50 million. The firm’s revenue for the quarter was up 47.1% compared to the same quarter last year. Equities analysts expect that Astera Labs, Inc. will post -0.45 earnings per share for the current year.

About Astera Labs

(Free Report)

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

Read More

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALABFree Report).

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.